Skip to Content

I 113 (Montelukast sodium (chewable) 5 mg (base))

Pill imprint I 113 has been identified as Montelukast sodium (chewable) 5 mg (base).

Montelukast is used in the treatment of allergic rhinitis; asthma, maintenance; bronchospasm prophylaxis; copd; asthma and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Montelukast 5 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).

Montelukast sodium (chewable) 5 mg (base) I 113 Front
Montelukast sodium (chewable) 5 mg (base) I 113 Back
Montelukast sodium (chewable) 5 mg (base) I 113
Discount Card Promo
Montelukast sodium (chewable)
I 113
5 mg (base)
Prescription only
Drug Class:
Leukotriene modifiers
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Camber Pharmaceuticals, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.